Tilray Medical, a division of Tilray Brands (TLRY), announced a strategic update to its medical cannabis operations in Italy with the launch of Tilray Medical Italia, the new name of the entity formerly known as FL Group.
The move to Tilray Medical Italia underscores the company’s effort to build a unified medical cannabis platform across Europe while strengthening its presence in one of the region’s key regulated markets.
Tilray Medical Italia is expanding its footprint in Italy through a growing portfolio of medical cannabis products authorized by the Italian Ministry of Health and supported by a partnership with Molteni Farmaceutici.
